Sigilon Therapeutics (SGTX) Short Interest Ratio & Short Volume → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free SGTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Sigilon Therapeutics Short Interest DataCurrent Short Volume8,200 sharesPrevious Short Volume10,100 sharesChange Vs. Previous Month-18.81%Dollar Volume Sold Short$171,544.00Short Interest Ratio / Days to Cover0.1Last Record DateJuly 31, 2023Outstanding Shares2,510,000 sharesFloat Size1,420,000 sharesShort Percent of Float0.58%Today's Trading Volume83,600 sharesAverage Trading Volume62,902 sharesToday's Volume Vs. Average133% Short Selling Sigilon Therapeutics ? Sign up to receive the latest short interest report for Sigilon Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSGTX Short Interest Over TimeSGTX Days to Cover Over TimeSGTX Percentage of Float Shorted Over Time Ad The TradingPubAt first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… Sigilon Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20238,200 shares $171,544.00 -18.8%0.6%0.1 $20.92 7/15/202310,100 shares $214,625.00 -1.0%0.7%0.1 $21.25 6/30/202310,200 shares $229,602.00 +7.4%0.7%0.1 $22.51 6/15/20239,500 shares $48,070.00 +6.7%0.7%1.2 $5.06 5/31/20238,900 shares $37,380.00 -15.2%0.6%0.6 $4.20 5/15/202310,500 shares $69,464.85 -93.3%N/A0.6 $6.62 Get the Latest News and Ratings for SGTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sigilon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/30/2023156,600 shares $114,318.00 +21.8%1.1%0.8 $0.73 4/15/2023128,600 shares $83,590.00 -5.8%0.9%0.6 $0.65 3/31/2023136,500 shares $126,958.65 -26.1%1.0%0.3 $0.93 3/15/2023184,600 shares $210,444.00 -24.9%1.3%0.5 $1.14 2/28/2023245,700 shares $267,813.00 +13.4%1.8%0.9 $1.09 2/15/2023216,700 shares $166,859.00 -5.6%1.0%0.9 $0.77 1/31/2023229,500 shares $166,066.20 +46.9%1.1%1 $0.72 1/15/2023156,200 shares $71,852.00 -5.1%0.7%0.7 $0.46 12/30/2022164,500 shares $57,575.00 -7.0%0.8%3.5 $0.35 12/15/2022176,800 shares $58,344.00 +11.8%0.9%3.7 $0.33 11/30/2022158,200 shares $62,394.08 +6.3%0.8%3.4 $0.39 11/15/2022148,800 shares $67,852.80 -5.9%0.8%3.6 $0.46 10/31/2022158,200 shares $79,416.40 +25.4%1.1%4.1 $0.50 10/15/2022126,200 shares $61,838.00 -9.7%0.9%3.1 $0.49 9/30/2022139,700 shares $70,548.50 -5.7%1.0%3.1 $0.51 9/15/2022148,200 shares $100,776.00 +6.5%1.0%2 $0.68 8/31/2022139,200 shares $86,526.72 +7.7%1.0%1.6 $0.62 8/15/2022129,300 shares $93,108.93 -9.6%0.9%1.3 $0.72 7/31/2022143,100 shares $101,601.00 +9.9%1.0%1.3 $0.71 7/15/2022130,200 shares $108,586.80 -17.3%0.9%1.1 $0.83 6/30/2022157,400 shares $130,642.00 -73.9%1.1%1.3 $0.83 6/15/2022603,300 shares $552,019.50 -9.2%4.3%5 $0.92 5/31/2022664,500 shares $503,691.00 +25.2%4.7%6.7 $0.76 5/15/2022530,600 shares $398,480.60 +11.6%3.7%5.9 $0.75 4/30/2022475,600 shares $499,380.00 +5.5%3.4%5.5 $1.05 4/15/2022450,800 shares $635,628.00 -4.1%3.2%5.1 $1.41 3/31/2022469,900 shares $690,753.00 +15.7%3.3%4.9 $1.47 3/15/2022406,200 shares $548,370.00 +13.3%2.9%3.9 $1.35 2/28/2022358,500 shares $519,825.00 +11.5%2.5%3 $1.45 2/15/2022321,500 shares $524,045.00 +31.8%2.3%2.3 $1.63 1/31/2022244,000 shares $475,800.00 +9.7%1.7%1.7 $1.95 1/15/2022222,400 shares $489,280.00 -4.7%1.6%1.5 $2.20 12/31/2021233,400 shares $644,184.00 -3.7%1.7%1.7 $2.76 12/15/2021242,400 shares $625,392.00 -15.5%1.7%1.8 $2.58At first glance, this chart looks like nonsense… (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… SGTX Short Interest - Frequently Asked Questions What is Sigilon Therapeutics' current short interest? Short interest is the volume of Sigilon Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 8,200 shares of SGTX short. 0.58% of Sigilon Therapeutics' shares are currently sold short. Learn More on Sigilon Therapeutics' current short interest. What is a good short interest percentage for Sigilon Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.58% of Sigilon Therapeutics' floating shares are currently sold short. Is Sigilon Therapeutics' short interest increasing or decreasing? Sigilon Therapeutics saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 8,200 shares, a decline of 18.8% from the previous total of 10,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Sigilon Therapeutics' float size? Sigilon Therapeutics currently has issued a total of 2,510,000 shares. Some of Sigilon Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sigilon Therapeutics currently has a public float of 1,420,000 shares. How does Sigilon Therapeutics' short interest compare to its competitors? 0.58% of Sigilon Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Sigilon Therapeutics: Kezar Life Sciences, Inc. (4.90%), Vaxxinity, Inc. (9.00%), Reneo Pharmaceuticals, Inc. (13.12%), Homology Medicines, Inc. (0.81%), Immuneering Co. (13.97%), SCYNEXIS, Inc. (2.59%), Checkpoint Therapeutics, Inc. (12.22%), HCW Biologics Inc. (0.09%), Eagle Pharmaceuticals, Inc. (10.59%), Gain Therapeutics, Inc. (1.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.34 billion), Occidental Petroleum Co. ($2.88 billion), Coinbase Global, Inc. ($2.50 billion), Rivian Automotive, Inc. ($2.47 billion), Palantir Technologies Inc. ($2.37 billion), Royal Caribbean Cruises Ltd. ($2.33 billion), T. Rowe Price Group, Inc. ($2.29 billion), Tractor Supply ($1.59 billion), Upstart Holdings, Inc. ($1.58 billion), and Enphase Energy, Inc. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Sigilon Therapeutics stock? Short selling SGTX is an investing strategy that aims to generate trading profit from Sigilon Therapeutics as its price is falling. SGTX shares are trading down $0.59 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sigilon Therapeutics? A short squeeze for Sigilon Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SGTX, which in turn drives the price of the stock up even further. How often is Sigilon Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SGTX, twice per month. The most recent reporting period available is July, 31 2023. More Short Interest Resources from MarketBeat Related Companies: Kezar Life Sciences Short Interest Data Vaxxinity Short Interest Data Reneo Pharmaceuticals Short Interest Data Homology Medicines Short Interest Data Immuneering Short Interest Data SCYNEXIS Short Interest Data Checkpoint Therapeutics Short Interest Data HCW Biologics Short Interest Data Eagle Pharmaceuticals Short Interest Data Gain Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SGTX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace